SAGE-217 reduces depressive symptoms in patients with major depression within 2 weeks
1. Patients with major depression randomized to receive SAGE-217, a positive allosteric modulator of γ-aminobutyric acid (GABA) type A receptors, ...
1. Patients with major depression randomized to receive SAGE-217, a positive allosteric modulator of γ-aminobutyric acid (GABA) type A receptors, ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.